Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brad Spellberg

Showing results (91-100 of 267) with videos related to

Pageof 27
Sort By:
Plos One|January 12, 2026
A monoclonal antibody raised against Acinetobacter baumannii capsular carbohydrate exhibits cross-species in vitro binding against Pseudomonas aeruginosaMatthew Slarve, Hadley Jaramillo, Brian Luna, et al.
Journal of Visualized Experiments : Jove|July 17, 2018
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial PneumoniaTravis B Nielsen, Jun Yan, Brian Luna, et al.
American Journal of Respiratory and Critical Care Medicine|January 16, 2015
Novel approaches are needed to develop tomorrow's antibacterial therapiesBrad Spellberg, John Bartlett, Rich Wunderink, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 25, 2020
Reply to Rybak et alWilliam F Wright, Sarah C J Jorgensen, Brad Spellberg
JAMA Network Open|June 23, 2025
Health Economic Analysis of an All-Virtual, At-Home Acute Care ModelBrad Spellberg, Christopher Lynch, Hal F Yee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2003
Lack of cross-hepatotoxicity between fluconazole and voriconazoleBrad Spellberg, Gunter Rieg, Arnold Bayer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 23, 2023
Early switch from intravenous to oral anti-microbial therapy in infectious diseasesParham Sendi, Sandra B Nelson, Alex Soriano, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2013
The FDA reboot of antibiotic developmentDavid M Shlaes, Dan Sahm, Carol Opiela, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 9, 2020
Heaping the Pelion of Vancomycin on the Ossa of Methicillin-resistant Staphylococcus aureus: Back to Basics in Clinical Care and GuidelinesWilliam F Wright, Sarah C J Jorgensen, Brad Spellberg
Msphere|August 4, 2025
Reply to "Limitations of repurposing ceftazidime for <i>Stenotrophomonas maltophilia</i>: a cautionary perspective"Matthew C Phillips, Rosemary She, Brad Spellberg, et al.
Pageof 27

Showing results (91-100 of 267) with videos related to

Sort By:
Pageof 27
Plos One|January 12, 2026
A monoclonal antibody raised against Acinetobacter baumannii capsular carbohydrate exhibits cross-species in vitro binding against Pseudomonas aeruginosaMatthew Slarve, Hadley Jaramillo, Brian Luna, et al.
Journal of Visualized Experiments : Jove|July 17, 2018
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial PneumoniaTravis B Nielsen, Jun Yan, Brian Luna, et al.
American Journal of Respiratory and Critical Care Medicine|January 16, 2015
Novel approaches are needed to develop tomorrow's antibacterial therapiesBrad Spellberg, John Bartlett, Rich Wunderink, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 25, 2020
Reply to Rybak et alWilliam F Wright, Sarah C J Jorgensen, Brad Spellberg
JAMA Network Open|June 23, 2025
Health Economic Analysis of an All-Virtual, At-Home Acute Care ModelBrad Spellberg, Christopher Lynch, Hal F Yee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2003
Lack of cross-hepatotoxicity between fluconazole and voriconazoleBrad Spellberg, Gunter Rieg, Arnold Bayer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 23, 2023
Early switch from intravenous to oral anti-microbial therapy in infectious diseasesParham Sendi, Sandra B Nelson, Alex Soriano, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2013
The FDA reboot of antibiotic developmentDavid M Shlaes, Dan Sahm, Carol Opiela, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 9, 2020
Heaping the Pelion of Vancomycin on the Ossa of Methicillin-resistant Staphylococcus aureus: Back to Basics in Clinical Care and GuidelinesWilliam F Wright, Sarah C J Jorgensen, Brad Spellberg
Msphere|August 4, 2025
Reply to "Limitations of repurposing ceftazidime for <i>Stenotrophomonas maltophilia</i>: a cautionary perspective"Matthew C Phillips, Rosemary She, Brad Spellberg, et al.
Pageof 27